Developed low dose vaccine to prevent nCoV
CureVac can produce a billion doses of nCoV vaccine from existing facilities if the trial is successful.First anti-coronary medication was tested with the 'gold standard' in the US
The National Institutes of Health on February 25 confirmed that the first clinical trial in the US for a new strain of corona virus treatment has begun at the University of